Post Tagged with: "Chemotherapy"

Thymomas and Thymic Carcinomas: A Review on Pathology, Presentation, Staging, Treatment, and Novel Systemic Therapies

Thymomas and Thymic Carcinomas: A Review on Pathology, Presentation, Staging, Treatment, and Novel Systemic Therapies

Respiratory October 26, 2017 at 8:23 AM 0 comments

Keisuke Miyamoto,1 *Jared D. Acoba1,2 1. Internal Medicine Department, University of Hawaii, Honolulu, Hawaii, USA 2. University of Hawaii Cancer Center, Honolulu, Hawaii, USA *Correspondence to jacoba@hawaii.edu Disclosure: The authors have declared no conflicts of interest. Received: 06.06.17 Accepted: 11.09.17 Citation: EMJ Respir. 2017;5[1]:100-107. Abstract Although thymomas and thymic carcinomasRead More

Chemotherapy for Extracranial Germ Cell Tumours in Paediatric, Adolescent, and Young Adult Patients

Chemotherapy for Extracranial Germ Cell Tumours in Paediatric, Adolescent, and Young Adult Patients

Oncology October 24, 2017 at 8:24 AM 0 comments

*Rong-Long Chen,1 Han-Ting Lin,2 Liuh-Yow Chen3 1. Department of Pediatric Hematology and Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan 2. Department of Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan 3. Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan *Correspondence to ronglongchen@yahoo.com.tw Disclosure: The authors haveRead More

Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology

Editor’s Pick: Protecting the Heart in Cancer Patients: The Role of Cardio-Oncology

Cardiology October 12, 2017 at 8:29 AM 0 comments

Our Editor’s pick for this issue is a thought-provoking paper from Ronald J. Krone, discussing the role cardio-oncology has in protecting the heart in cancer patients. Collaboration between oncologists and cardio-oncologists is imperative in developing cardiologists with expertise in understanding the impact that various cancer regimens have on the heartRead More

microRNAS in Therapy Resistance of Breast Cancer

microRNAS in Therapy Resistance of Breast Cancer

Oncology November 22, 2016 at 8:22 AM 0 comments

Janine Jung, Vinona Wagner, *Cindy Körner Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany *Correspondence to c.koerner@dkfz-heidelberg.de Disclosure: The authors have declared no conflicts of interests. Received: 29.09.16 Accepted: 07.11.16 Citation: EMJ Oncol. 2016;4[1]:103-112. Abstract Breast cancer is one of the deadliest cancer types worldwideRead More

Update: Diagnosis and Treatment of Muscle- Invasive and Metastatic Bladder Cancer in 2014

Update: Diagnosis and Treatment of Muscle- Invasive and Metastatic Bladder Cancer in 2014

Urology September 5, 2014 at 12:18 PM 0 comments

*Johannes Bründl, Philipp J. Spachmann, Maximilian Burger Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Regensburg, Germany *Correspondence to johannes.bruendl@ukr.de Disclosure: No potential conflict of interest. Abstract Bladder cancer (BC) is the ninth most commonly diagnosed malignant tumour in the world, with an incidence of about 356,000Read More

Skin Reactions Secondary to Anticancer Agents

Skin Reactions Secondary to Anticancer Agents

Dermatology November 11, 2013 at 10:52 PM 0 comments

Gabriella Fabbrocini,1 Rosanna Izzo,2 Luigia Panariello,3 Giuseppe Monfrecola4 1. Associate Professor, Venereal and Cutaneous Diseases, Division of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy 2. Doctor, Department of Clinical Medicine and Surgery, University of Naples ‘Federico II’, Italy 3. Specialist, Clinical Dermatology, UniversityRead More